Skip to main content
. 2021 Sep 8;2021(9):CD009437. doi: 10.1002/14651858.CD009437.pub3

Trappenburg 2011.

Study characteristics
Methods RCT; follow‐up 6 months; control group: usual care
Participants Eligible: 391
Randomised: 233, I: 111, C: 122
Completed: 193, I: 91, C: 102
Mean age: I: 66 years, C: 65 years
Sex (% male): I: 65, C: 69
Inclusion criteria: COPD diagnosed by spirometry, age > 40 years, smoking history > 20 years or 15 pack‐years, diagnosis of COPD as a major functionally limiting disease, current use of bronchodilator therapy
Major exclusions: primary diagnosis of asthma, primary diagnosis of cardiac disease, presence of disease that could affect mortality or participation in the study
Interventions 6‐month self‐management/action plan programme
‐ Individualised action plan with treatment prescriptions related to color‐coded symptom status to enhance adequate response to periods of symptom deterioration
‐ Action plan included ongoing support of case manager, in concordance with GP/respiratory physician. 2 reinforcement sessions provided by telephone at 1 and 4 months
Intervention duration: 6 months
Disciplines involved: GP, nurse, pulmonologist
Outcomes Exacerbation rate and recovery time; SGRQ; HADS; courses of antibiotics, corticosteroids; ED visits for exacerbation; CCQ score during exacerbation
Notes Dominant component: self‐management/action plan
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "randomisation was carried out using the minimization technique to balance the control and intervention groups for centre and gender"
Allocation concealment (selection bias) Low risk Quote: "to conceal the assignment sequence, a central web‐based service was used"
Blinding of participants and personnel (performance bias)
All outcomes Low risk Quote: "an informed consent to postponed information procedure is used, keeping the patient unaware of the AP being the major study aim. This implies that all patients are informed about the fact that, besides the outcome assessment aiming at gaining more insight in daily symptom variations, the study has another purpose. Patients are told that they will be informed about this additional research question only after follow up because informing during recruitment would affect study results"
Blinding of outcome assessment (detection bias)
All outcomes Low risk Quote: "investigators were blinded to allocation"
Incomplete outcome data (attrition bias)
All outcomes Low risk Quote: "monthly discontinuation rates and reasons for withdrawal are comparable in both study arms"
Selective reporting (reporting bias) Low risk Comment: study protocol is not available, but it is clear that published reports include all expected outcomes, including those that were pre‐specified